Mackenzie Financial’s Prometheus Biosciences, Inc. Common Stock RXDX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-2,139	Closed	-$230K	–	1673
2023 Q1	$230K	Sell	2,139 -54	-2%	-$5.8K	﹤0.01%	1298
2022 Q4	$241K	Buy	+2,193	New	+$241K	﹤0.01%	1164